VERMAFIL LX/HX

Strong Innovation in Product Design

Perfected fiber characteristics including better geometry, distribution and more uniform pore sizes. 

Optimized fiber packing density

Redesigned headers and housing, composed of polypropylene material

Improved polyurethane potting surface

Guaranteed BPAfree dialyzers, removing the risk of endocrine disruption associated to Bisphenol A.

Tangible Technical Advantages

Maximized fiber capillary usage.

Increased mechanical fiber strength.

Enhanced blood and dialysate flows

Superior Results for HD Patients

Outstanding clearance of uremic toxins and low molecular weight proteins.

Excellent middle molecule removal.

Preserved essential proteins like albumin.

Superior biocompatibility

Lower risk of thrombogenicity.

Convenient packaging.

Ease and versatility of treatment options.

Safer dialyzers, offering highly reliable, patient-oriented dialysis therapies.

Value Added Features

Comprehensive range of surface areas.

Removable patient label to facilitate treatment documentation.

Convenient packaging.

Lower weight, reducing waste and logistic costs, while having a greener environmental impact. 

CE 0476 UNI CEI EN ISO 13485-2016

RMA

Verma

One of the leading companies in the field of haemodialysis in Greece

For 5 decades, our company is characterized by continuous growth and development, enjoying the trust and recognition of doctors and patients. ‘Our vision is to explore new horizons in the field of Renal Failure in Greece and also to establish ourselves as an international leading force. True to our established strategy, we are constantly expanding into new activities, increasing the range of our products, while at the same time intensifying our export activities. The result is a continuous upgrade of our services to our customers and the improvement of the Quality of Life of patients with Renal Failure.